Cargando…
Enhanced immune reaction resulting from co-vaccination of WT1 helper peptide assessed on PET-CT
It has become evident that positron emission tomography/computed tomography (PET-CT) using 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) (FDG PET-CT) can detect anti-tumor immune response induced by various immunotherapies. To evaluate whether FDG PET-CT could detect anti-cancer immune response caused by c...
Autores principales: | Nakata, Jun, Isohashi, Kayako, Morimoto, Soyoko, Itou, Ryota, Kamiya, Takashi, Matsuura, Ai, Nakajima, Hiroko, Fujiki, Fumihiro, Nishida, Sumiyuki, Hasii, Yoshiko, Hasegawa, Kana, Nakatsuka, Shinichi, Hosen, Naoki, Tsuboi, Akihiro, Oka, Yoshihiro, Kumanogoh, Atsushi, Shibano, Masaru, Munakata, Satoru, Oji, Yusuke, Hatazawa, Jun, Sugiyama, Haruo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523872/ https://www.ncbi.nlm.nih.gov/pubmed/32991475 http://dx.doi.org/10.1097/MD.0000000000022417 |
Ejemplares similares
-
Immune adjuvant therapy using Bacillus Calmette–Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments
por: Nishida, Sumiyuki, et al.
Publicado: (2019) -
Imaging Assessment of Tumor Response in the Era of Immunotherapy
por: Nakata, Jun, et al.
Publicado: (2021) -
Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides
por: Nakata, Jun, et al.
Publicado: (2018) -
Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine
por: Takashima, Satoshi, et al.
Publicado: (2016) -
A phase I clinical study of a cocktail vaccine of Wilms’ tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma
por: Tsuboi, Akihiro, et al.
Publicado: (2018)